SMARCE1 Gene Meningioma Familial Susceptibility to Genetic Test sale cost 4400 AED
IDH1 Gene IDH1 Selective Sequencing of Exon 4 Genetic Test sale cost 4400 AED IDH1 Gene IDH1 Selective Sequencing of Exon 4 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test sale cost 4400 AED CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SMARCE1 Gene Meningioma Familial Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SMARCE1 Gene Meningioma Familial Susceptibility Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the SMARCE1 gene that are associated with an increased risk of developing meningioma, a type of brain tumor. Meningiomas are typically slow-growing tumors that form from the membranes covering the brain and spinal cord (meninges). Although many meningiomas are benign, they can be life-altering and, in rare cases, malignant.

The test is particularly relevant for individuals with a family history of meningioma or those who have a personal history of multiple meningiomas, as it can provide crucial information for risk assessment and management. Identifying a mutation in the SMARCE1 gene can help healthcare providers develop a personalized surveillance plan to detect and treat meningiomas early, potentially improving outcomes.

The cost of the SMARCE1 Gene Meningioma Familial Susceptibility Genetic Test at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, typically through a blood draw or a cheek swab, and comprehensive analysis in the lab. The test is conducted with strict confidentiality and precision, ensuring that patients receive accurate and useful information regarding their genetic risk for meningioma.

Given the implications of the test results for both the individual tested and potentially their family members, genetic counseling is often recommended as part of the testing process. This ensures that individuals fully understand the implications of the test results and can make informed decisions about their health and future surveillance options.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SMARCE1 Gene Meningioma Familial Susceptibility to Genetic Test

Welcome to DNA Labs UAE, a leading genetic lab offering a comprehensive range of genetic tests. In this blog post, we will discuss the SMARCE1 Gene Meningioma familial susceptibility to genetic test, its components, cost, symptoms, diagnosis, and more.

Test Details

The SMARCE1 gene is associated with a condition called familial meningioma, which is a genetic susceptibility to develop meningiomas. Meningiomas are tumors that originate in the meninges, the protective membranes that surround the brain and spinal cord.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the detection of genetic variations that may contribute to the development of certain diseases or conditions. In the case of familial meningioma, NGS genetic testing can identify mutations or variants in the SMARCE1 gene that may increase the risk of developing meningiomas.

This type of genetic testing can be helpful for individuals with a family history of meningiomas, as it can provide information about their personal risk of developing the condition. It can also be used for genetic counseling and to inform medical management and screening recommendations for at-risk individuals.

It’s important to note that genetic testing for familial meningioma is typically performed in a clinical setting, and the results should be interpreted by a healthcare professional with expertise in genetics. They can provide appropriate counseling and guidance based on the individual’s test results and family history.

Test Name

SMARCE1 Gene Meningioma familial susceptibility to Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for SMARCE1 Gene Meningioma, familial, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SMARCE1 Gene Meningioma, familial, susceptibility to NGS Genetic DNA Test gene SMARCE1.

For more information or to schedule a test, please contact our Genetics Test Department.

Test Name SMARCE1 Gene Meningioma familial susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SMARCE1 Gene Meningioma, familial, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SMARCE1 Gene Meningioma, familial, susceptibility to NGS Genetic DNA Test gene SMARCE1
Test Details

The SMARCE1 gene is associated with a condition called familial meningioma, which is a genetic susceptibility to develop meningiomas. Meningiomas are tumors that originate in the meninges, the protective membranes that surround the brain and spinal cord.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the detection of genetic variations that may contribute to the development of certain diseases or conditions. In the case of familial meningioma, NGS genetic testing can identify mutations or variants in the SMARCE1 gene that may increase the risk of developing meningiomas.

This type of genetic testing can be helpful for individuals with a family history of meningiomas, as it can provide information about their personal risk of developing the condition. It can also be used for genetic counseling and to inform medical management and screening recommendations for at-risk individuals.

It’s important to note that genetic testing for familial meningioma is typically performed in a clinical setting, and the results should be interpreted by a healthcare professional with expertise in genetics. They can provide appropriate counseling and guidance based on the individual’s test results and family history.

SKU: TEST-4525 Category:

Related products